Skip to main content
Top
Published in: La radiologia medica 3/2016

01-03-2016 | ABDOMINAL RADIOLOGY

Prognostic utility of diffusion-weighted MRI in oesophageal cancer: is apparent diffusion coefficient a potential marker of tumour aggressiveness?

Authors: Francesco Giganti, Annalaura Salerno, Alessandro Ambrosi, Damiano Chiari, Elena Orsenigo, Antonio Esposito, Luca Albarello, Elena Mazza, Carlo Staudacher, Alessandro Del Maschio, Francesco De Cobelli

Published in: La radiologia medica | Issue 3/2016

Login to get access

Abstract

Purpose

To investigate the role of the apparent diffusion coefficient (ADC) as a potential prognostic biomarker in the evaluation of the aggressiveness of oesophageal cancer.

Materials and methods

Between November 2009 and December 2013, 43 patients with evidence of oesophageal or oesophago-gastric junction cancer were referred to our institution and prospectively entered in our database. The final study population consisted of 23 patients (18 men; 5 women; mean age, 64.62 ± 10.91 years) who underwent diffusion-weighted Magnetic Resonance before surgical intervention. Specifically, 14 were directly treated with surgery and 9 were addressed to chemo/radiotherapy beforehand. Two radiologists independently measured mean tumour ADC and inter-observer agreement (Spearman’s and intraclass correlation coefficient [ICC]) was assessed. In the univariate analysis, overall survival curves related to pathological ADC, pT, pN, tumour location and histotype were fitted using the Kaplan–Meier method. Survival curves were then compared using the log-rank test.

Results

Inter-observer reproducibility was very good (Spearman’s rho = 0.95; ICC = 0.94). At a total median follow-up of 19 months (2–49 months), 4 patients had died. The median follow-up was 18.50 months (5–49 months) for the surgery-only group (1/4 events, 25 %) and 24 months (2–34 months) for the chemo/radiotherapy group (3/4 events, 75 %). Survival time at 48 months for the overall population was 59 % (±0.11), while for the surgery-only group and the chemo/radiotherapy group was 90 % (±0.09) and 61 % (±0.34), respectively. In the univariate analysis, ADC values below or equal to 1.4 × 10−3 mm2/s were associated with a negative prognosis both in the total population (P = 0.016) and in the surgery-only group (P < 0.001).

Conclusion

Despite the biggest limitation of our study (i.e. the small study population), we were able to show that pathological ADC could be considered a prognostic factor for oesophageal cancer. DWI might be introduced into clinical practice as a promising and reliable technique in the diagnostic pathway of this tumour.
Literature
1.
3.
go back to reference Dhupar R, Correa AM, Ajani J et al (2014) Concordance of studies for nodal staging is prognostic for worse survival in esophageal cancer. Dis Esophagus 27(8):770–776CrossRefPubMed Dhupar R, Correa AM, Ajani J et al (2014) Concordance of studies for nodal staging is prognostic for worse survival in esophageal cancer. Dis Esophagus 27(8):770–776CrossRefPubMed
4.
go back to reference Courrech Staal EF, Aleman BM, Boot H, van Velthuysen ML, van Tinteren H, van Sandick JW (2010) Systematic review of the benefits and risks of Neoadjuvant chemoradiation for oesophageal cancer. Br J Surg 97(10):1482–1496CrossRefPubMed Courrech Staal EF, Aleman BM, Boot H, van Velthuysen ML, van Tinteren H, van Sandick JW (2010) Systematic review of the benefits and risks of Neoadjuvant chemoradiation for oesophageal cancer. Br J Surg 97(10):1482–1496CrossRefPubMed
5.
go back to reference Sjoquist KM, Burmeister BH, Smithers BM et al (2011) Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta analysis. Lancet Oncol 12:681–692CrossRefPubMed Sjoquist KM, Burmeister BH, Smithers BM et al (2011) Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta analysis. Lancet Oncol 12:681–692CrossRefPubMed
6.
go back to reference Urschel J, Vasan H (2003) A meta-analysis of randomized controlled trials that compared Neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 185:538–543CrossRefPubMed Urschel J, Vasan H (2003) A meta-analysis of randomized controlled trials that compared Neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 185:538–543CrossRefPubMed
7.
go back to reference Bedenne L, Michel P, Bouché O et al (2007) Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 25(10):1160–1168CrossRefPubMed Bedenne L, Michel P, Bouché O et al (2007) Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 25(10):1160–1168CrossRefPubMed
8.
go back to reference Jamil LH, Gill KR, Wallace MB (2008) Staging and restaging of advanced esophageal cancer. Curr Opin Gastroenterol 24:530–534CrossRefPubMed Jamil LH, Gill KR, Wallace MB (2008) Staging and restaging of advanced esophageal cancer. Curr Opin Gastroenterol 24:530–534CrossRefPubMed
9.
go back to reference Kim TJ, Kim HY, Lee KW, Kim MS (2009) Multimodality assessment of esophageal cancer: preoperative staging and monitoring of response to therapy. Radiographics 29:403–421CrossRefPubMed Kim TJ, Kim HY, Lee KW, Kim MS (2009) Multimodality assessment of esophageal cancer: preoperative staging and monitoring of response to therapy. Radiographics 29:403–421CrossRefPubMed
10.
go back to reference Ishibashi Y, Hanyu N, Nakada K et al (2003) Endothelin protein expression as a significant prognostic factor in oesophageal squamous cell carcinoma. Eur J Cancer 39:1409–1415CrossRefPubMed Ishibashi Y, Hanyu N, Nakada K et al (2003) Endothelin protein expression as a significant prognostic factor in oesophageal squamous cell carcinoma. Eur J Cancer 39:1409–1415CrossRefPubMed
11.
go back to reference Miyata H, Doki Y, Shiozaki H et al (2000) CDC25B and p53 are independently implicated in radiation sensitivity for human esophageal cancers. Clin Cancer Res 6:4859–4865PubMed Miyata H, Doki Y, Shiozaki H et al (2000) CDC25B and p53 are independently implicated in radiation sensitivity for human esophageal cancers. Clin Cancer Res 6:4859–4865PubMed
12.
go back to reference Foley KG, Fielding P, Lewis WG et al (2014) Prognostic significance of novel 18F-FDG PET/CT defined tumour variables in patients with oesophageal cancer. Eur J Radiol 83(7):1069–1073CrossRefPubMed Foley KG, Fielding P, Lewis WG et al (2014) Prognostic significance of novel 18F-FDG PET/CT defined tumour variables in patients with oesophageal cancer. Eur J Radiol 83(7):1069–1073CrossRefPubMed
13.
go back to reference Palie O, Michel P, Ménard JF et al (2013) The predictive value of treatment response using FDG PET performed on day 21 of chemoradiotherapy in patients with oesophageal squamous cell carcinoma. A prospective, multicentre study (RTEP3). Eur J Nucl Med Mol Imaging 40(9):1345–1355CrossRefPubMed Palie O, Michel P, Ménard JF et al (2013) The predictive value of treatment response using FDG PET performed on day 21 of chemoradiotherapy in patients with oesophageal squamous cell carcinoma. A prospective, multicentre study (RTEP3). Eur J Nucl Med Mol Imaging 40(9):1345–1355CrossRefPubMed
14.
go back to reference De Cobelli F, Giganti F, Orsenigo E et al (2013) Apparent diffusion coefficient modifications in assessing gastro-oesophageal cancer response to neoadjuvant treatment: comparison with tumour regression grade at histology. Eur Radiol 23(8):2165–2174CrossRefPubMed De Cobelli F, Giganti F, Orsenigo E et al (2013) Apparent diffusion coefficient modifications in assessing gastro-oesophageal cancer response to neoadjuvant treatment: comparison with tumour regression grade at histology. Eur Radiol 23(8):2165–2174CrossRefPubMed
15.
go back to reference Hein PA, Kremser C, Judmaier W et al (2013) Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study. Eur J Radiol 45:214–222CrossRef Hein PA, Kremser C, Judmaier W et al (2013) Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study. Eur J Radiol 45:214–222CrossRef
16.
go back to reference Fangberget A, Nilsen LB, Hole KH et al (2011) Neoadjuvant chemotherapy in breast cancer-response evaluation of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging. Eur Radiol 21:1188–1199PubMedCentralCrossRefPubMed Fangberget A, Nilsen LB, Hole KH et al (2011) Neoadjuvant chemotherapy in breast cancer-response evaluation of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging. Eur Radiol 21:1188–1199PubMedCentralCrossRefPubMed
17.
go back to reference Sakurada A, Takahara T, Kwee TC et al (2009) Diagnostic performance of diffusion-weighted magnetic resonance imaging in esophageal cancer. Eur Radiol 19:1461–1469CrossRefPubMed Sakurada A, Takahara T, Kwee TC et al (2009) Diagnostic performance of diffusion-weighted magnetic resonance imaging in esophageal cancer. Eur Radiol 19:1461–1469CrossRefPubMed
18.
go back to reference Aoyagi T, Shuto K, Okazumi S et al (2010) Evaluation of the clinical staging of esophageal cancer by using diffusion-weighted imaging. Exp Ther Med 1:847–852 Aoyagi T, Shuto K, Okazumi S et al (2010) Evaluation of the clinical staging of esophageal cancer by using diffusion-weighted imaging. Exp Ther Med 1:847–852
19.
go back to reference Wang L, Han C, Zhu S et al (2014) Investigation of using diffusion-weighted magnetic resonance imaging to evaluate the therapeutic effect of oesophageal carcinoma treatment. Oncol Res Treat 37(3):112–116CrossRefPubMed Wang L, Han C, Zhu S et al (2014) Investigation of using diffusion-weighted magnetic resonance imaging to evaluate the therapeutic effect of oesophageal carcinoma treatment. Oncol Res Treat 37(3):112–116CrossRefPubMed
20.
go back to reference Aoyagi T, Shuto K, Okazumi S, Shimada H, Kazama T, Matsubara H (2011) Apparent diffusion coefficient values measured by diffusion weighted imaging predict chemoradiotherapeutic effect for advanced esophageal cancer. Dig Surg 28:25–27CrossRef Aoyagi T, Shuto K, Okazumi S, Shimada H, Kazama T, Matsubara H (2011) Apparent diffusion coefficient values measured by diffusion weighted imaging predict chemoradiotherapeutic effect for advanced esophageal cancer. Dig Surg 28:25–27CrossRef
21.
go back to reference Giganti F, Orsenigo E, Esposito A et al (2015) Prognostic role of diffusion-weighted MR imaging for resectable gastric cancer. Radiology 276:444–452CrossRefPubMed Giganti F, Orsenigo E, Esposito A et al (2015) Prognostic role of diffusion-weighted MR imaging for resectable gastric cancer. Radiology 276:444–452CrossRefPubMed
22.
go back to reference Van Rossum PS, van Hillegersberg R, Lever FM et al (2013) Imaging strategies in the management of oesophageal cancer: what’s the role of MRI? Eur Radiol 23(7):1753–1765CrossRefPubMed Van Rossum PS, van Hillegersberg R, Lever FM et al (2013) Imaging strategies in the management of oesophageal cancer: what’s the role of MRI? Eur Radiol 23(7):1753–1765CrossRefPubMed
23.
go back to reference Siewert JR, Stein HJ (1998) Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 85:1457–1459CrossRefPubMed Siewert JR, Stein HJ (1998) Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 85:1457–1459CrossRefPubMed
24.
go back to reference Van Hagen P, Hulshof MC, van Lanschot JJ et al (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366(22):2074–2084CrossRefPubMed Van Hagen P, Hulshof MC, van Lanschot JJ et al (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366(22):2074–2084CrossRefPubMed
25.
go back to reference Hasegawa S, Yoshikawa T, Aoyama T et al (2013) Esophagus or stomach? The seventh TNM classification for Siewert type II/III junctional adenocarcinoma. Ann Surg Oncol 20(3):773–779CrossRefPubMed Hasegawa S, Yoshikawa T, Aoyama T et al (2013) Esophagus or stomach? The seventh TNM classification for Siewert type II/III junctional adenocarcinoma. Ann Surg Oncol 20(3):773–779CrossRefPubMed
26.
go back to reference Giganti F, De Cobelli F, Canevari C et al (2014) Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and 18F-FDG-PET/CT: correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade. J Magn Reson Imaging 40(5):1147–1157CrossRefPubMed Giganti F, De Cobelli F, Canevari C et al (2014) Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and 18F-FDG-PET/CT: correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade. J Magn Reson Imaging 40(5):1147–1157CrossRefPubMed
27.
go back to reference Riddell AM, Hillier J, Brown G et al (2006) Potential of surface-coil MRI for staging of esophageal cancer. AJR Am J Roentgenol 187(5):1280–1287CrossRefPubMed Riddell AM, Hillier J, Brown G et al (2006) Potential of surface-coil MRI for staging of esophageal cancer. AJR Am J Roentgenol 187(5):1280–1287CrossRefPubMed
28.
go back to reference Dave UR, Williams AD, Wilson JA et al (2004) Esophageal cancer staging with endoscopic MR imaging: pilot study. Radiology 230(1):281–286CrossRefPubMed Dave UR, Williams AD, Wilson JA et al (2004) Esophageal cancer staging with endoscopic MR imaging: pilot study. Radiology 230(1):281–286CrossRefPubMed
29.
go back to reference Jeh SK, Kim SH, Kim HS et al (2011) Correlation of the apparent diffusion coefficient value and dynamic magnetic resonance imaging findings with prognostic factors in invasive ductal carcinoma. J Magn Reson Imaging 33(1):102–109CrossRefPubMed Jeh SK, Kim SH, Kim HS et al (2011) Correlation of the apparent diffusion coefficient value and dynamic magnetic resonance imaging findings with prognostic factors in invasive ductal carcinoma. J Magn Reson Imaging 33(1):102–109CrossRefPubMed
30.
go back to reference Imanishi S, Shuto K, Aoyagi T, Kono T, Saito H, Matsubara H (2013) Diffusion-weighted magnetic resonance imaging for predicting and detecting the early response to chemoradiotherapy of advanced esophageal squamous cell carcinoma. Dig Sug 30:240–248CrossRef Imanishi S, Shuto K, Aoyagi T, Kono T, Saito H, Matsubara H (2013) Diffusion-weighted magnetic resonance imaging for predicting and detecting the early response to chemoradiotherapy of advanced esophageal squamous cell carcinoma. Dig Sug 30:240–248CrossRef
Metadata
Title
Prognostic utility of diffusion-weighted MRI in oesophageal cancer: is apparent diffusion coefficient a potential marker of tumour aggressiveness?
Authors
Francesco Giganti
Annalaura Salerno
Alessandro Ambrosi
Damiano Chiari
Elena Orsenigo
Antonio Esposito
Luca Albarello
Elena Mazza
Carlo Staudacher
Alessandro Del Maschio
Francesco De Cobelli
Publication date
01-03-2016
Publisher
Springer Milan
Published in
La radiologia medica / Issue 3/2016
Print ISSN: 0033-8362
Electronic ISSN: 1826-6983
DOI
https://doi.org/10.1007/s11547-015-0585-2

Other articles of this Issue 3/2016

La radiologia medica 3/2016 Go to the issue